Correlation Between Biodexa Pharmaceticals and Oncorus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Oncorus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Oncorus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Oncorus, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Oncorus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Oncorus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Oncorus.

Diversification Opportunities for Biodexa Pharmaceticals and Oncorus

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biodexa and Oncorus is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Oncorus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncorus and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Oncorus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncorus has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Oncorus go up and down completely randomly.

Pair Corralation between Biodexa Pharmaceticals and Oncorus

If you would invest  4.35  in Oncorus on September 2, 2024 and sell it today you would earn a total of  0.00  from holding Oncorus or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy1.56%
ValuesDaily Returns

Biodexa Pharmaceticals  vs.  Oncorus

 Performance 
       Timeline  
Biodexa Pharmaceticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biodexa Pharmaceticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Oncorus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncorus has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Oncorus is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Biodexa Pharmaceticals and Oncorus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biodexa Pharmaceticals and Oncorus

The main advantage of trading using opposite Biodexa Pharmaceticals and Oncorus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Oncorus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncorus will offset losses from the drop in Oncorus' long position.
The idea behind Biodexa Pharmaceticals and Oncorus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Insider Screener
Find insiders across different sectors to evaluate their impact on performance